Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Part of paid clinical trials in Houston, Texas.

Sponsor
University of Zurich
Study ID
NCT06417710
Status
Recruiting
Apply to this trial

Conditions

  • Leptomeningeal Cancer
  • Leptomeningeal Disease
  • Leptomeningeal Metastasis
  • Leptomeningeal Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Neurological Assessment — OTHER
    Clinical neurological assessment performed by 2 raters

Study Details

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Key Dates

Start date
Jan 30, 2022
Status verified
May 2024
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

inter-observer agreement of response assessment of the overall clinical assessment - per center and among all raters [ Time Frame: December 2026 ]

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Barbara O'Brien
[email protected]
832-837-9347

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies